HQY Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Healthequity Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 78.55 USD -1.5%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast HQY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HQY is 101.22 USD with a low forecast of 92.92 USD and a high forecast of 115.5 USD.

HQY Lowest Forecast

Wall Street Target

HQY Average Forecast

Wall Street Target

HQY Highest Forecast

Wall Street Target

18% Upside

29% Upside

47% Upside

The latest public price target was made on Apr 4, 2024 by Constantine Davides from JMP Securities , who expects HQY stock to rise by 29% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Constantine Davides JMP Securities	101 USD Upside 29%	1 month ago Apr 4, 2024	JMP Securities Starts HealthEquity, Inc (HQY) at Market Outperform, 'We expect HQY to continue its share gains' StreetInsider
Glen Santangelo Jefferies	95 USD Upside 21%	1 month ago Mar 28, 2024	HealthEquity, Inc (HQY) PT Raised to $95 at Jefferies, 'confident in biz trends and magnitude of tailwinds' StreetInsider
Sean Dodge RBC Capital	92 USD Upside 17%	1 month ago Mar 20, 2024	HealthEquity, Inc (HQY) PT Raised to $92 at RBC Capital StreetInsider
Stephanie Davis Barclays	104 USD Upside 32%	1 month ago Mar 20, 2024	Barclays Reiterates Overweight Rating on HealthEquity, Inc (HQY) StreetInsider
Mark Marcon Robert W. Baird	87 USD Upside 11%	7 months ago Sep 21, 2023	Baird Upgrades HealthEquity, Inc (HQY) to Outperform StreetInsider
Scott Schoenhaus Loop Capital Markets	85 USD Upside 8%	10 months ago Jun 6, 2023	HealthEquity To Capture More Market Share, Says Analyst In Overweight Rating Rationale Benzinga

Show More Price Targets

Show Less Price Targets

Price Target	101 USD
Upside/Downside	29%

Price Target	95 USD
Upside/Downside	21%

Price Target	92 USD
Upside/Downside	17%

Price Target	104 USD
Upside/Downside	32%

Price Target	87 USD
Upside/Downside	11%

Price Target	85 USD
Upside/Downside	8%

Show More Price Targets

Show Less Price Targets

Elevance Health Inc

17% Upside

Molina Healthcare Inc

21% Upside

Progyny Inc

50% Upside

Odontoprev SA

6% Upside

Elevance Health Inc

17% Upside

Molina Healthcare Inc

21% Upside

Progyny Inc

50% Upside

Odontoprev SA

6% Upside

UnitedHealth Group Inc

17% Upside

Revenue
Forecast

For the last 8 years the compound annual growth rate for Healthequity Inc's revenue is 29%. The projected CAGR for the next 3 years is 14%.

29%

14%

-1%

What are analyst estimates?

Operating Income
Forecast

For the last 8 years the compound annual growth rate for Healthequity Inc's operating income is 22%. The projected CAGR for the next 3 years is 39%.

22%

39%

-33%

What are analyst estimates?

Net Income
Forecast

For the last 8 years the compound annual growth rate for Healthequity Inc's net income is 16%. The projected CAGR for the next 3 years is 91%.

16%

91%

-40%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for HQY is 101.22 USD with a low forecast of 92.92 USD and a high forecast of 115.5 USD.

For the last 8 years the compound annual growth rate for Healthequity Inc's revenue is 29%. The projected CAGR for the next 3 years is 14%.

For the last 8 years the compound annual growth rate for Healthequity Inc's operating income is 22%. The projected CAGR for the next 3 years is 39%.

For the last 8 years the compound annual growth rate for Healthequity Inc's net income is 16%. The projected CAGR for the next 3 years is 91%.

Join more than 134,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.